Evidence map›Paper›PMID 40722004›Full record

ArticleScandinavian journal of immunology2025

Multiparametric Optimization of Human Primary B-Cell Cultures Using Design of Experiments.

Anne Bruun Rovsing, Kenneth Green, Lisbeth Jensen, Ian Helstrup Nielsen, Jacob Giehm Mikkelsen, Søren E Degn

Abstract read
In one paragraph

Article in Scandinavian journal of immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anne Bruun RovsingDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Kenneth GreenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Lisbeth JensenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Ian Helstrup NielsenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Jacob Giehm MikkelsenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Søren E DegnDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID https://orcid.org/0000-0001-5409-045X

Funding

Aase og Ejnar Danielsens Fond 23-10-0252Danmarks Frie Forskningsfond 9039-00173Danmarks Frie Forskningsfond 9060-00038NEYE-Fonden
6 · The paper itself

Abstract

B cells are essential in the immune system, driving antibody production, cytokine secretion and antigen presentation. Studies in mouse models have illuminated key mechanisms underlying B-cell activation, differentiation, class-switch recombination and somatic hypermutation. However, the extent to which these findings translate to human biology remains unclear. To address this, we developed a human primary B-cell culture system using feeder cells engineered to express CD40L, supplemented with the cytokines BAFF, IL-4 and IL-21. Using a Design of Experiments (DOE) approach, we optimised critical parameters and dissected the individual contributions of each specific factor. Our results reveal that BAFF plays a negligible role, and IL-21 has more subtle effects, whereas CD40L and IL-4 are critical determinants of cell viability, proliferation and IgE class-switching. Furthermore, we find that engineered feeder cells can serve equally well as a source of cytokines, but providing these in purified form increases the flexibility of the system. This platform enables detailed investigation of human B-cell biology, offering insights into intrinsic and extrinsic regulators of antibody responses and providing a foundation for in vitro production of human primary antibodies.

Indexed as

B-LymphocytesCell Culture TechniquesB-Cell Activating FactorCD40 LigandCell DifferentiationCell ProliferationCells, CulturedCell SurvivalCytokinesFeeder CellsHumansImmunoglobulin Class SwitchingImmunoglobulin EInterleukin-21Interleukin-4InterleukinsB-Cell Activating FactorCD40 LigandCytokinesImmunoglobulin EInterleukin-21Interleukin-4InterleukinsTNFSF13B protein, humanB‐cell cultureCD40LIL‐4

Identifiers

PMID40722004
PMCPMC12304294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.